Breast cancer risk can be lowered by avoiding unnecessary medical imaging — UCSF analysis of IOM report on environmental causes of breast cancer suggests there is at least 1 way women can reduce risk – A report issued by the Institute of Medicine (IOM) last December reviewed all the available scientific data compiled to date about potential environmental risks of breast cancer?factors such as pesticides, beauty products, household chemicals, and the plastics used to make water bottles.
Task Force Examines Evidence to Update Hormone Therapy Recommendations – Evidence of significant adverse events led the U.S. Preventive Services Task Force to issue recommendations against using estrogen plus progestin in 2002 and estrogen alone in 2005 to prevent chronic conditions.
HRT-breast cancer risk stays same, regardless of family history – HRT conveys no greater breast cancer risk to women with, versus without, a first-degree family history of breast cancer. – The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.
Danish study provides new information on hormone replacement therapy and the risk of heart attacks – It’s not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe’s leading cardiology journal, the European Heart Journal.
Acupuncture reduces side effects of breast cancer treatment as much as conventional drug therapy. Therapy shown to increase energy and overall well-being for breast cancer patients. – Acupuncture is as effective and longer-lasting in managing the common debilitating side effects of hot flashes, night sweats, and excessive sweating (vasomotor symptoms) associated with breast cancer treatment and has no treatment side effects compared to conventional drug therapy, according to a first-of-its-kind study presented September 24, 2008, at the American Society for Therapeutic Radiology and Oncology’s 50th Annual Meeting in Boston.
Women with prothrombotic mutations or a high body mass index should avoid oral oestrogens, but transdermal preparations seem to be safer. – Hormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, revealed by researchers in British Medical Journal, UK. Women who take the oral form of HRT more than double their risk of developing a blood clot.
Hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence in breast cancer survivors. – A new study HABITS revealed that breast cancer survivors who took hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence than those who did not take HRT.
The longer a woman uses the oral contraceptive pill, the lower her risk of getting ovarian cancer later in life. Oral contraceptives give substantial long-term protection against ovarian cancer. – Use of oral contraceptives during a woman’s life-time gives substantial long-term protection against ovarian cancer and the longer they are used, the greater the reduction in risk. These are the conclusions of authors of an Article in this week’s edition of The Lancet – a medical journal in the United Kingdom.